These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 1346939

  • 21. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
    Karow A, Reimer J, Schäfer I, Krausz M, Haasen C, Verthein U.
    Drug Alcohol Depend; 2010 Dec 01; 112(3):209-15. PubMed ID: 20728288
    [Abstract] [Full Text] [Related]

  • 22. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
    Kling MA, Carson RE, Borg L, Zametkin A, Matochik JA, Schluger J, Herscovitch P, Rice KC, Ho A, Eckelman WC, Kreek MJ.
    J Pharmacol Exp Ther; 2000 Dec 01; 295(3):1070-6. PubMed ID: 11082442
    [Abstract] [Full Text] [Related]

  • 23. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.
    J Subst Abuse Treat; 2006 Jul 01; 31(1):3-7. PubMed ID: 16814005
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M, Beck O, Leifman A, Romelsjö A, Helander A.
    Drug Alcohol Rev; 2007 Jan 01; 26(1):55-63. PubMed ID: 17364837
    [Abstract] [Full Text] [Related]

  • 26. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM.
    Addiction; 2009 May 01; 104(5):775-83. PubMed ID: 19344438
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Methadone maintenance and clonidine detoxification in the treatment of opiate addicts in Israel: suggesting evidence for cultural differences in the effectiveness of treatment modalities for opiate addiction.
    ShahamY, Shufman, Scher, Barel, Zlotogorski, Cohen.
    Isr J Psychiatry Relat Sci; 1991 May 01; 28(3):45-57. PubMed ID: 1666067
    [Abstract] [Full Text] [Related]

  • 29. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC, Oviedo-Joekes E, Perea-Milla E, Carrasco F, PEPSA team.
    J Subst Abuse Treat; 2006 Sep 01; 31(2):203-11. PubMed ID: 16919749
    [Abstract] [Full Text] [Related]

  • 30. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
    Nava F, Manzato E, Lucchini A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1089-94. PubMed ID: 17466429
    [Abstract] [Full Text] [Related]

  • 31. [4 years' methadone substitution therapy in Austria].
    Loimer N.
    Wien Klin Wochenschr; 1992 Jun 30; 104(19):583-8. PubMed ID: 1441552
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD, Grebely J, Tossonian H, Wong T, Viljoen M, Khara M, Mead A, McLean M, Duncan F, Petkau AJ, DeVlaming S, Conway B.
    Drug Alcohol Depend; 2007 Jul 10; 89(2-3):306-9. PubMed ID: 17383117
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine.
    Kreek MJ.
    Ann N Y Acad Sci; 2000 Jul 10; 909():186-216. PubMed ID: 10911931
    [Abstract] [Full Text] [Related]

  • 36. [Pregnant opioid addicted patients and additional drug intake. Part I. Toxic effects and therapeutic consequences].
    Hoell I, Havemann-Reinecke U.
    Med Monatsschr Pharm; 2011 Oct 10; 34(10):363-74; quiz 375-6. PubMed ID: 22010420
    [Abstract] [Full Text] [Related]

  • 37. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J, Verthein U, Karow A, Schäfer I, Naber D, Haasen C.
    Addiction; 2011 Sep 10; 106(9):1647-55. PubMed ID: 21489005
    [Abstract] [Full Text] [Related]

  • 38. Methadone maintenance and recovery from opioid dependence.
    Maddux JF, Desmond DP.
    Am J Drug Alcohol Abuse; 1992 Sep 10; 18(1):63-74. PubMed ID: 1562007
    [Abstract] [Full Text] [Related]

  • 39. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
    Sullivan MA, Rothenberg JL, Vosburg SK, Church SH, Feldman SJ, Epstein EM, Kleber HD, Nunes EV.
    Am J Addict; 2006 Sep 10; 15(2):150-9. PubMed ID: 16595353
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.